-
Product Insights
Innovation in construction: floating breakwaters
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s floating breakwaters segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
NewC-C Chemokine Receptor Type 8 – Drugs In Development, 2024
The C-C Chemokine Receptor Type 8 pipeline drugs market research report outlays comprehensive information on the C-C Chemokine Receptor Type 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Toxicology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Opioid Induced Side Effects, Alzheimer's Disease, and Neuropathic Pain (Neuralgia). It also...
-
Product Insights
NewC-X-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Respiratory, and Metabolic Disorders which include indications of Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Inflammation, Autoimmune Disorders, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewNonstructural Protein 5A – Drugs In Development, 2024
The Nonstructural Protein 5A pipeline drugs market research report outlays comprehensive information on the Nonstructural Protein 5A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Immunology, and Metabolic Disorders which include indications of Hepatitis C, Hepatitis B, Prostate Cancer, Melanoma, Inflammation, and Obesity. It also reviews key players involved in Nonstructural Protein 5A targeted...
-
Product Insights
NewC-C Motif Chemokine 2 – Drugs In Development, 2024
The C-C Motif Chemokine 2 pipeline drugs market research report outlays comprehensive information on the C-C Motif Chemokine 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, and Gastrointestinal which include indications of Oncology, Ovarian Cancer, Dry (Atrophic) Macular Degeneration, Diabetic Retinopathy, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). It also...
-
Product Insights
NewATP Binding Cassette Sub Family C Member 8 – Drugs In Development, 2024
The ATP Binding Cassette Sub Family C Member 8 pipeline drugs market research report outlays comprehensive information on the ATP Binding Cassette Sub Family C Member 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Type 2 Diabetes, Gestational Diabetes, and Central Nerve Injury. It also reviews...
-
Product Insights
NewProtein Kinase C Theta Type – Drugs In Development, 2024
The Protein Kinase C Theta Type pipeline drugs market research report outlays comprehensive information on the Protein Kinase C Theta Type targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Unspecified Cancer, Breast Cancer, Rheumatoid Arthritis, Inflammation, Obesity, Type 2 Diabetes, and Atopic Dermatitis (Atopic Eczema). It also...
-
Product Insights
NewNucleotide Binding Oligomerization Domain Containing Protein 2 – Drugs In Development, 2024
The Nucleotide Binding Oligomerization Domain Containing Protein 2 pipeline drugs market research report outlays comprehensive information on the Nucleotide Binding Oligomerization Domain Containing Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Gastrointestinal, Infectious Disease, and Immunology which include indications of Colorectal Cancer, Melanoma, Crohn's Disease (Regional Enteritis), Ileitis, Human Immunodeficiency Virus (HIV) Infections (AIDS),...
-
Product Insights
NewC-X-C Chemokine Receptor Type 3 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 3 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Ophthalmology which include indications of Unspecified Cancer, Solid Tumor, Autoimmune Disorders, Unspecified Immunological Disorders, Type 1 Diabetes (Juvenile Diabetes), and Wet (Neovascular /...
-
Product Insights
NewVascular Endothelial Growth Factor C – Drugs In Development, 2024
The Vascular Endothelial Growth Factor C pipeline drugs market research report outlays comprehensive information on the Vascular Endothelial Growth Factor C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, Hematological Disorders, and Undisclosed which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Solid Tumor, Triple-Negative Breast Cancer (TNBC), Lymphedema, and Unspecified....